CHARACTERISTICS OF CYTOKINE STATUS OF CHILDREN WITH ACUTE BRONCHIOLITIS

FULL TEXT:

Abstract

The original article presents the results of a clinical and laboratory study, as well as a study of the cytokine profile in young children with acute bronchiolitis. Changes in the content of interleukins are recommended to be used as markers for predicting the severity of the disease.


Purpose of the study: Study of the features of cytokine status in young children with acute bronchiolitis.


Materials and methods of research: 36 children with acute bronchiolitis aged 1-12 months, hospitalized in the period 2022-2023, were examined. in the departments of emergency pediatrics and pediatric intensive care. All children had bronchial obstruction of varying severity. To assess the prognosis of the severity of bronchiolitis, a scoring scale was used based on clinical and auscultatory signs of ESBA(J.M. Ramos Fernаndez et all, 2013). All patients underwent laboratory and instrumental examination: general blood test blood gas study, oxygen saturation (SpO2), chest x-ray. To determine the level of IL-6, IL-8, TNF ά, the enzyme-linked immunosorbent assay method was used.To detect viral antigen (RSV, adenovirus, rhinovirus, parainfluenza), a real-time polymerase chain reaction was performed using commercial kits “Reverta” and “Amplisense-200” (Russia). To determine the causative agent of infections (Chlamydia pneumonia, Mycoplasma pneumonia), an enzyme-linked immunosorbent assay (ELISA) was performed using a standard commercial set of reagents “CHEMA” (Russia).


The results: For the first time in the region, the Acute Bronchiolitis Severity Scale (ESBA) was used, which includes clinical parameters, with the help of which the child’s condition is assessed during the initial examination by a doctor, before the use of instrumental research methods. The study of interferon status showed that the highest pathological level of interleukins was observed when RSV was combined with Chlamydia pneumonia (n=3) (IL-8 - 39.66±0.66 ng/ml, IL-6 - 47.33±1.20 ng/ml, TNFα 69.0±9.6 ng/ml), while the level of interleukins during RSV monoinfection (n=19) also remained at a high level, not significantly different from the previous group (IL-8 - 39.021±0, 92 ng/ml, IL-6 – 43.68±1.75 ng/ml, TNFα 60.7±3.68 ng/ml).


Conclusion. A relationship was revealed between the expression of interleukins and the severity of acute bronchiolitis, which is characterized by an increase in the concentration of IL-6, IL-8 and TNFα depending on the severity of the disease. Changes in interleukins are recommended to be used as markers for predicting the severity of the disease.

About the Authors

List of references

Azimova K.T., Garifulina L. M., Features of the Clinical Characteristics of Acute Bronchiolitis in Children in Relationship with Cytokine Status // American Journal of Medicine and Medical Sciences-2023.-№13 (5).-P. 647-652. DOI: 10.5923/j.ajmms.20231305.21

Azimova K.T., Garifulina L.M. Risk factors for severe acute bronchiolitis in young children // Journal of Problems of Biology and Medicine-2023.-№2 (142). -P.25-31.

Avdeev S.N. Respiratory failure: definition, classification, approaches to diagnosis and therapy // Respiratory medicine / edited by A.G. Chuchalin. M.: GEOTAR-Media, 2007. Vol. 2. P. 658–668.

Afanasyeva O.I. et al. Cytokine status indicators in children with ARVI during therapy with intranasal interferon preparations // Children's infections. 2021 – 20(4) – P.6–12. DOI: https://doi.org/10.22627/2072-8107-2021-20-4-6-12

Baranova N.I. The role of cytokines IL-4, IL-6, IL-8, IL-10 in the immunopathogenesis of chronic obstructive pulmonary disease // Medical immunology. – 2019 - No. 1 (21) – P. 89–98. DOI: https://doi.org/10.15789/1563-0625-2019-1-89-98

Baranov A.A. et al. Modern approaches to the management of children with acute bronchiolitis // Pediatric pharmacology - 2019 - No. 6 (volume 16). - P. 339- 348 DOI: https://doi.org/10.15690/pf.v16i6.2071

Maidannik V.G., Emchinskaya E.A. Modern approaches to the diagnosis and treatment of bronchiolitis in children from the standpoint of evidence-based medicine // Practical medicine. 2013 - 5 (74) - P. 7-16.

Shay D.K., Holman R.C., Newman R.D. et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996 // JAMA ―1999. ―Vol. 282, No. 15. ― P. 1440-1446. DOI: https://doi.org/10.1001/jama.282.15.1440

Meissner H.C. Bronchiolitis. In: Long S.S., Pickering L.K., Prober C.G. Principles and Practice of Pediatric Infectious Diseases. 3rd. New York: Churchill Livingstone, Elsevier. - 2008. - P. 241-245. DOI: https://doi.org/10.1016/B978-0-7020-3468-8.50041-9

Rivas-Juesas C, et al. A comparison of two clinical scores for bronchiolitis. A multicentre and prospective study conducted in hospitalized infants. Allergol Immunopathol (Madr). 2017. http://dx.doi.org/10.1016/j.aller.2017.01.012Allergol Immunopathol (Madr). 2017. http://dx.doi.org/10.1016/j.aller.2017.01.012 DOI: https://doi.org/10.1016/j.aller.2017.01.012

How to Cite

Azimova К. ., & Garifulina Л. (2024). CHARACTERISTICS OF CYTOKINE STATUS OF CHILDREN WITH ACUTE BRONCHIOLITIS. International Journal of Scientific Pediatrics, 3(7), 669–672. https://doi.org/10.56121/2181-2926-2024-3-7-669-672
Views: 0